John Temperato
2021 - 9 METERS BIOPHARMA
In 2021, John Temperato earned a total compensation of $2.2M as President and Chief Executive Officer at 9 METERS BIOPHARMA, a 6% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $214,840 |
|---|---|
| Option Awards | $1,435,854 |
| Salary | $537,100 |
| Total | $2,187,794 |
Temperato received $1.4M in option awards, accounting for 66% of the total pay in 2021.
Temperato also received $214.8K in non-equity incentive plan and $537.1K in salary.
Rankings
In 2021, John Temperato's compensation ranked 5,713th out of 12,415 executives tracked by ExecPay. In other words, Temperato earned more than 54.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,713 out of 12,415 | 54th |
Division Manufacturing | 2,425 out of 5,505 | 56th |
Major group Chemicals And Allied Products | 1,051 out of 2,375 | 56th |
Industry group Drugs | 938 out of 2,096 | 55th |
Industry Pharmaceutical Preparations | 675 out of 1,546 | 56th |
Source: SEC filing on May 13, 2022.
Temperato's colleagues
We found one more compensation record of an executive who worked with John Temperato at 9 METERS BIOPHARMA in 2021.
2021
Edward Sitar
9 METERS BIOPHARMA